Cargando…

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()

INTRODUCTION: Closures and reductions in capacity of select health and social services in response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a disproportionately increased risk for experiencing harms, and resulted in critical treatment disruptions. We conducted the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Cayley, Ali, Farihah, Nafeh, Frishta, Rehm, Jürgen, LeBlanc, Sean, Elton-Marshall, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757985/
https://www.ncbi.nlm.nih.gov/pubmed/34080545
http://dx.doi.org/10.1016/j.jsat.2021.108374
_version_ 1784851942848069632
author Russell, Cayley
Ali, Farihah
Nafeh, Frishta
Rehm, Jürgen
LeBlanc, Sean
Elton-Marshall, Tara
author_facet Russell, Cayley
Ali, Farihah
Nafeh, Frishta
Rehm, Jürgen
LeBlanc, Sean
Elton-Marshall, Tara
author_sort Russell, Cayley
collection PubMed
description INTRODUCTION: Closures and reductions in capacity of select health and social services in response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a disproportionately increased risk for experiencing harms, and resulted in critical treatment disruptions. We conducted the current national study among a cohort of PWUD to understand how COVID-19 has affected service access, including any significant impacts PWUD may have experienced. Results will contribute to the evidence base for informing future pandemic and public health policy planning for vulnerable populations. METHODS: The project involved qualitative telephone-based interviews with 196 adult (aged 18+) PWUD from across Canada. Eligibility criteria included daily or weekly use of psychoactive substance(s), and/or current enrollment in opioid agonist treatment (OAT). Data collection took place between May and July 2020. Data underwent thematic analyses, and common themes informed the results. RESULTS: Most participants experienced detrimental service access issues and treatment disruptions during COVID-19, including reduced access to harm reduction services, OAT, withdrawal management and treatment services, medical professionals (e.g., addictions and mental health counseling), shelters/housing, and food banks. Positive impacts included greater access to OAT take-home ‘carries’ and prescription deliveries. Decreases in service capacity resulted in increased health issues and risky substance use behaviors among PWUD, such as unaccompanied substance use, sharing/re-use of supplies, and overdose events. CONCLUSIONS: Reductions in the accessibility of critical services PWUD rely on during COVID-19 has increased existent substance use and health issues among PWUD, while decreasing their ability to mitigate risks related to substance use. Thus, the expansion of the depth and breadth of support options is crucial. Services must remain open and flexible to the unique needs of PWUD during COVID-19, while novel and effective adaptations and interventions should remain available and accessible post-COVID-19.
format Online
Article
Text
id pubmed-9757985
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97579852022-12-19 Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study() Russell, Cayley Ali, Farihah Nafeh, Frishta Rehm, Jürgen LeBlanc, Sean Elton-Marshall, Tara J Subst Abuse Treat Article INTRODUCTION: Closures and reductions in capacity of select health and social services in response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a disproportionately increased risk for experiencing harms, and resulted in critical treatment disruptions. We conducted the current national study among a cohort of PWUD to understand how COVID-19 has affected service access, including any significant impacts PWUD may have experienced. Results will contribute to the evidence base for informing future pandemic and public health policy planning for vulnerable populations. METHODS: The project involved qualitative telephone-based interviews with 196 adult (aged 18+) PWUD from across Canada. Eligibility criteria included daily or weekly use of psychoactive substance(s), and/or current enrollment in opioid agonist treatment (OAT). Data collection took place between May and July 2020. Data underwent thematic analyses, and common themes informed the results. RESULTS: Most participants experienced detrimental service access issues and treatment disruptions during COVID-19, including reduced access to harm reduction services, OAT, withdrawal management and treatment services, medical professionals (e.g., addictions and mental health counseling), shelters/housing, and food banks. Positive impacts included greater access to OAT take-home ‘carries’ and prescription deliveries. Decreases in service capacity resulted in increased health issues and risky substance use behaviors among PWUD, such as unaccompanied substance use, sharing/re-use of supplies, and overdose events. CONCLUSIONS: Reductions in the accessibility of critical services PWUD rely on during COVID-19 has increased existent substance use and health issues among PWUD, while decreasing their ability to mitigate risks related to substance use. Thus, the expansion of the depth and breadth of support options is crucial. Services must remain open and flexible to the unique needs of PWUD during COVID-19, while novel and effective adaptations and interventions should remain available and accessible post-COVID-19. The Author(s). Published by Elsevier Inc. 2021-10 2021-03-19 /pmc/articles/PMC9757985/ /pubmed/34080545 http://dx.doi.org/10.1016/j.jsat.2021.108374 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Russell, Cayley
Ali, Farihah
Nafeh, Frishta
Rehm, Jürgen
LeBlanc, Sean
Elton-Marshall, Tara
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title_full Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title_fullStr Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title_full_unstemmed Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title_short Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
title_sort identifying the impacts of the covid-19 pandemic on service access for people who use drugs (pwud): a national qualitative study()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757985/
https://www.ncbi.nlm.nih.gov/pubmed/34080545
http://dx.doi.org/10.1016/j.jsat.2021.108374
work_keys_str_mv AT russellcayley identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy
AT alifarihah identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy
AT nafehfrishta identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy
AT rehmjurgen identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy
AT leblancsean identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy
AT eltonmarshalltara identifyingtheimpactsofthecovid19pandemiconserviceaccessforpeoplewhousedrugspwudanationalqualitativestudy